ALS (motor neurone disease) trials in Poland

In Poland 9 Also abroad 226

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Where
Bydgoszcz, Krakow, Warsaw
Age
18 years to 80 years
People
500 worldwide
Run by
Prilenia
See details and how to joinNCT07322003
Phase 1/2Taking people
A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.
Where
Krakow, Warsaw
Age
18 years to 80 years
People
80 worldwide
Run by
Nura Bio
See details and how to joinNCT07369076
Phase 1/2Taking people
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Where
Krakow, Warsaw, Zabrze
Age
18 years and over
People
54 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06351592 · EU 2023-510344-20-00
Phase 2Taking people
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Where
Cracow, Warsaw
Age
18 years and over
People
240 worldwide
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT07023835 · EU 2025-522580-15-00
Phase 2Taking people
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
Where
Krakow, Warsaw
Age
18 years to 75 years
People
105 worldwide
Run by
PhenoNet, Inc.
See details and how to joinNCT07142291
Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Where
Bydgoszcz, Cracow, Warsaw
Age
18 years and over
People
420 worldwide
Run by
Ferrer Internacional S.A.
See details and how to join2025-524002-16-00 · EU 2025-524002-16-00
No phaseEnrolling by invitation
Electrophysiology and Ultrasound of Respiratory Muscles and Respective Nerves to Predict Respiratory Insufficiency in ALS
Where
Krakow
Age
18 years to 80 years
People
80
Run by
Jagiellonian University
See details and how to joinNCT06841341
Phase 3Taking people
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Where
Bydgoszcz
Age
18 years to 81 years
People
495 worldwide
Run by
AB Science
See details and how to joinNCT03127267
No phaseTaking people
Polish Version Fatigue Severity Scale
Where
Krakow, Warsaw
Age
18 years and over
People
310
Run by
Jakub Antczak
See details and how to joinNCT06668649